Project Description

CSA Medical

STATUS:

Exited

At CSA Medical®, we aim to be the leading global provider of innovative spray cryotherapy medical device solutions that improve patient outcomes, simplify procedures, and reduce the cost of healthcare.

Our truFreeze® spray cryotherapy technology uses extremely cold liquid nitrogen (-196° C) to provide targeted, touchless ablation of unwanted tissue inside the body under direct visualization.

New Markets Team Member:

Robb Doub

Sector:

Healthcare